North America Dominated the Nucleic Acid Isolation and Purification Market in Terms Of Revenue Generated in the Global Market
Nucleic acid isolation and purification is the preliminary step in the field of molecular biology research accompanied with recombinant techniques. The nucleic acid isolation process majorly includes enzymatic digestion and mechanical and chemical disruption. On the other hand, purification consists of the combination of precipitation, chromatography, centrifugation, electrophoresis, and separation.
The
process of nucleic acid isolation aids sample processing by reducing the time,
significantly minimizes nucleic acid loss, and enhances experimental process
efficiency and effectiveness. The obtained purified product is further used in
recombinant technology methods, thereby making it suitable for targeted
purposes in the field of omics research. The advantages offered by nucleic acid
isolation and purification significantly aid scientists and researchers to
obtain high-quality starting material for conducting downstream applications,
thereby generating accurate results.
According
to the market intelligence published by BIS Research the nucleic
acid isolation and purification market is projected to grow at a
significant CAGR of 5.98% during the forecast period, 2020-2029. The market was
estimated at $2273.9 million in 2018.
Nucleic
acid isolation and purification enabled end users are expected to witness wide
variety of applications, and automation has further facilitated applications
such as genomic/plasmid DNA, cell-free DNA (cfDNA), viral RNA, and cell-free
RNA (cfRNA). Automation in nucleic acid isolation and purification offers high
throughput, further reducing sample processing time.
Factors
such as increasing prevalence of genetic diseases, rising research in the field
of molecular biology, growing awareness and acceptance of precision medicine
worldwide, and rising research funding from government and private
institutions, among others, are further supporting the adoption of automated
nucleic acid isolation and purification products.
As
of 2019, North America is the dominating region in terms of revenue generated
in the global market. The presence of full-fledged operational units of
conglomerate companies contributing to this market significantly provided help
in the establishment of several emerging players, further contributing
significantly to the technological innovations in the nucleic acid isolation
and purification market.
In
the Europe region, Germany, the U.K., and France are the dominating countries
in the Europe nucleic acid isolation and purification market. Factors such as
growing demand for pharmaceuticals, increasing genomic research by government
and private institutions, and significant adoption of technologically advanced
nucleic acid isolation products, among others, are expected to support the
market growth in the forthcoming years.
Comments
Post a Comment